Trials / Sponsors / Neonc Technologies, Inc.
Neonc Technologies, Inc.
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors Pediatric Tumor of CNS, Pediatric Tumor of Brain, Diffuse Midline Glioma, H3 K27M-Mutant | Phase 1 | 2026-01-01 |
| Recruiting | Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Meta Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult | Phase 1 / Phase 2 | 2023-11-01 |
| Recruiting | NEO100 and High-Grade Meningioma Residual, Progressive or Recurrent Grade II or III Meningioma | Phase 2 | 2022-07-01 |
| Recruiting | Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma Glioblastoma Multiforme | Phase 1 / Phase 2 | 2017-08-01 |